The Business Research Company’s report on the Medical Foods For Inborn Errors Of Metabolism Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
How are market drivers shaping the future growth trajectory of the medical foods for inborn errors of metabolism industry?
The rise in genetic (inherited) disorders is expected to propel the growth of medical foods for inborn errors in the metabolism market going forward. Genetic (inherited) disorders refer to a disease that is entirely or partially brought on by a deviation from the typical DNA sequence. Medical foods are essential for infants with metabolic abnormalities to deliver specialized nutrition created to address the unique metabolic requirements of people with these illnesses, thereby assisting in the prevention of nutritional deficits and metabolic needs for promoting their growth and well-being. For instance, in May 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based public health agency, sickle cell disease (SCD) affects about 100,000 people in the United States. More than 90% of those affected are non-Hispanic Black or African American, while an estimated 3%–9% are Hispanic or Latino. Therefore, the rise in genetic (inherited) disorders is driving the growth of medical foods for inborn errors of metabolism market.
Access Your Free Sample of the Global Medical Foods For Inborn Errors Of Metabolism Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12161&type=smp
What is the estimated market size of the medical foods for inborn errors of metabolism sector by 2029, based on current forecasts?
The medical foods for inborn errors of metabolism market size has grown rapidly in recent years. It will grow from $3.08 billion in 2024 to $3.47 billion in 2025 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to global health initiatives, increased recognition of nutritional therapies, precision medicine approaches, increasing incidence of metabolic disorders, and personalized digital nutrition platforms
The medical foods for inborn errors of metabolism market size is expected to see rapid growth in the next few years. It will grow to $5.43 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to telehealth integration, rising demand for clean-label products, expanded newborn screening programs, patient-centric care models, and plant-based and sustainable formulations. Major trends in the forecast period include technological advancements in genetic testing, advancements in food processing technologies, innovations in ingredient technology, and technological advancements in food formulation.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=12161&type=smp
Who are the top players in the medical foods for inborn errors of metabolism market?
Major companies operating in the medical foods for inborn errors of metabolism market include Nestlé Health Science, Abbott Laboratories, Danone Nutricia, Vitaflo International Ltd., BioMarin Pharmaceutical Inc., Cambrooke Therapeutics Inc., Galen US Inc., Nutricia North America, Solace Nutrition LLC, Nutricia Advanced Medical Nutrition, Ajinomoto Cambrooke Inc., Primus Pharmaceuticals Inc., Applied Nutrition Corp., Metagenics Inc., PKU Perspectives Inc., Medtrition Inc., Nutricia Pty Ltd., Arla Foods Ingredients Group P/S, Aegle Nutrition LLC, Homestat Farm Ltd., Ketovie Nutrition, Formulaid, International Nutrition Inc., Phesgo Medical Foods, Immedica Pharma AB, Meiji Holdings Co. Ltd.
What are the major trends in the medical foods for inborn errors of metabolism market?
Product innovation has emerged as a key trend gaining popularity in medical food for inborn errors in the metabolism market. Major companies operating in medical food for inborn errors in the metabolism market are concentrating on creating innovative products to strengthen their position in the market. For Instance, in October 2023, Galen Limited, a UK-based pharmaceutical company, launched PKU Easy Microtabs Plus as part of their Medical Nutrition range. PKU Easy Microtabs Plus is designed to assist in the dietary management of Phenylketonuria (PKU), a metabolic disorder. The product offers patients a more convenient and accurate method of controlling their phenylalanine levels through small, easy-to-swallow microtabs. This innovative formulation is aimed at improving the quality of life for individuals with PKU by allowing for better dose customization and ease of use.
Which geography holds the highest medical foods for inborn errors of metabolism market share?
North America was the dominant region in the medical foods for inborn errors of metabolism market in 2024. The regions covered in the medical foods for inborn errors of metabolism market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
How do different segments contribute to the overall expansion of the medical foods for inborn errors of metabolism market?
The medical foods for inborn errors of metabolism market covered in this report is segmented –
1) By Product: Amino Acid, Glytactin With GMP Amino Acid-Modified Infant Formula with Iron, Low-Calcium Or Vitamin D-Free Infant Formula With Iron, Low Protein Food, Other Products
2) By Diseases: Phenylketonuria (PKU), Maple Syrup Urine Disease (MSUD), Homocystinuria, Methylmalonic Acidemia, Organic Acidurias, Propionic Acidemia, Isovaleric Acidemia, Disorders Of Leucine Metabolism, Glutaric Acidemia Type I Renal Disease, Other Diseases
3) By Age Group: Infants, Weaning, Adolescent, Adults
4) By Forms: Powder, Liquids, Gels, Other Forms
5) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Drugs Stores, Online Pharmacies, Other Distribution Channels
Subsegments:
1) By Amino Acid: Powdered Amino Acid Formulas, Liquid Amino Acid Formulas
2) By Glytactin With GMP Amino Acid-Modified Infant Formula With Iron: Glytactin Powder, Glytactin Ready-To-Use Formulations, GMP Formulas For Specific Conditions, Standard GMP Amino Acid-Modified Formulas
3) By Low-Calcium Or Vitamin D-Free Infant Formula With Iron: Liquid Low-Calcium Or Vitamin D-Free Formulas, Powdered Low-Calcium Or Vitamin D-Free Formulas
4) By Low Protein Food: Low Protein Pasta And Noodles, Low Protein Snacks, Low Protein Bakery Products
5) By Other Products: Specialized Supplements, Nutritional Bars, Ready-To-Use Therapeutic Foods
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12161
How is the medical foods for inborn errors of metabolism market defined?
A medical food for inborn errors of metabolism refers to dietary supplements provided to people with genetic conditions that influence their metabolic functions. The dietary requirements of people with these diseases are managed, and these items provide particular nutrients.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
